C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development ROR
  • Office of Extramural Research ROR
  • George Mason University ROR
  • University of Utah ROR
  • Intermountain Healthcare ROR
  • Commonwealth Medical College ROR

Fertility and sterility, 109(2), 232-239.e1

DOI 10.1016/j.fertnstert.2017.10.025 PMID 29317123

Abstract

Objective

To assess systemic inflammation in relation to fecundability and anovulation.

Design

Prospective cohort study among participants in the Effects of Aspirin in Gestation and Reproduction trial who were assigned to the placebo.

Setting

Academic medical centers. PATIENT(S): Healthy eumenorrheic women (n = 572), 18-40 years of age, with one or two pregnancy losses, attempting spontaneous pregnancy. INTERVENTION(S): Baseline serum high-sensitivity C-reactive protein (hsCRP) values <10 mg/L were categorized into tertiles. MAIN OUTCOME MEASURE(S): Discrete Cox proportional hazards models estimated the fecundability odds ratio (FOR) and 95% confidence interval (CI) and adjusted for potential confounders. Log-binomial regression estimated the risk ratio (RR) and 95% CI of anovulation. The algorithm to define anovulation used data on urinary concentrations of hCG, pregnanediol-3-glucuronide, and LH as well as fertility monitor readings. RESULT(S): Higher hsCRP was associated with reduced fecundability but not with an increased risk of anovulation. CONCLUSION(S): Among healthy women attempting pregnancy after one or two pregnancy losses, we found preliminary evidence that systemic inflammation is associated with reduced fecundability, but not independently from adiposity. Sporadic anovulation did not appear to drive this association. Clinical

Trial Registration Number

ClinicalTrials.gov: NCT00467363.

Topics

Radin Sjaarda Silver C-reactive protein fecundability anovulation eumenorrheic women, systemic inflammation CRP fertility conception rate anovulation association, EAGeR trial placebo arm CRP fecundability prospective cohort pregnancy loss history, high-sensitivity CRP inflammatory biomarker ovulatory dysfunction female fertility, inflammation-mediated anovulation fecundity reduction CRP threshold fertility, Fertility Sterility 2018 CRP anovulation fecundability eumenorrheic women cohort, subclinical inflammation reproductive function ovarian follicular development, C-reactive protein concentration time to pregnancy anovulatory cycle frequency, aspirin placebo CRP levels fecundability effect modification inflammation, immune-endocrine interaction inflammation ovulation disruption conception delay
PMID 29317123 29317123 DOI 10.1016/j.fertnstert.2017.10.025 10.1016/j.fertnstert.2017.10.025

Cite this article

Radin, R. G., Sjaarda, L. A., Silver, R. M., Nobles, C. J., Mumford, S. L., Perkins, N. J., Wilcox, B. D., Pollack, A. Z., Schliep, K. C., Plowden, T. C., & Schisterman, E. F. (2018). C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women. *Fertility and sterility*, *109*(2), 232-239.e1. https://doi.org/10.1016/j.fertnstert.2017.10.025

Related articles